This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Fenchone is an ingredient used in medication to treat kidney, bladder, and urinary tract stones.
- Generic Name
- Fenchone
- DrugBank Accession Number
- DB15918
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Fenchone (DB15918)
- Weight
- Average: 152.237
Monoisotopic: 152.120115135 - Chemical Formula
- C10H16O
- Synonyms
- (+/-)-Fenchone
- DL-Fenchone
- Fenchon
- External IDs
- 214-804-6
- NSC-122687
- NSC-8896
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image URINEX (Enteric-Coated) Soft Gelatin Capsules Fenchone (4 mg) + Anethole (4 mg) + Borneol (10 mg) + Camphene (15 mg) + Eucalyptol (3 mg) + alpha-Pinene (24.8 mg) + beta-Pinene (6.2 mg) Capsule, gelatin coated Oral Pharco Health Sdn. Bhd 2020-09-08 Not applicable Malaysia 
โรวาทีเน็ก Fenchone (4 mg) + Anethole (4 mg) + Borneol (10 mg) + Camphene (15 mg) + Eucalyptol (3 mg) + alpha-Pinene (24.8 mg) + beta-Pinene (6.2 mg) Capsule บริษัท ดีซีเอช ออริกา (ประเทศไทย) จำกัด 1987-05-22 Not applicable Thailand 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4Q6W8568TG
- CAS number
- 1195-79-5
- InChI Key
- LHXDLQBQYFFVNW-OIBJUYFYSA-N
- InChI
- InChI=1S/C10H16O/c1-9(2)7-4-5-10(3,6-7)8(9)11/h7H,4-6H2,1-3H3/t7-,10+/m0/s1
- IUPAC Name
- (1R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one
- SMILES
- CC1(C)[C@H]2CC[C@](C)(C2)C1=O
References
- General References
- FDA Thailand: Rowatinex (Anethole, Borneol, Camphene, Eucalyptol, Fenchone, Alpha-Pinene, Beta-Pinene) Capsule [Link]
- External Links
- ChemSpider
- 74207
- ChEBI
- 36612
- ZINC
- ZINC000000967570
- Wikipedia
- Fenchone
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule, gelatin coated Oral Capsule - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.883 mg/mL ALOGPS logP 2.54 ALOGPS logP 3.06 Chemaxon logS -2.2 ALOGPS pKa (Strongest Basic) -7.6 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 17.07 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 44.54 m3·mol-1 Chemaxon Polarizability 17.86 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at November 23, 2020 14:47 / Updated at May 07, 2021 21:08